- Home
- CAMT vs HAE Comparison
CAMT vs HAE Comparison
Compare CAMT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAMT
- HAE
- Stock Information
- Founded
- CAMT 1987
- HAE 1971
- Country
- CAMT Israel
- HAE United States
- Employees
- CAMT N/A
- HAE N/A
- Industry
- CAMT Electronic Components
- HAE Medical/Dental Instruments
- Sector
- CAMT Technology
- HAE Health Care
- Exchange
- CAMT Nasdaq
- HAE Nasdaq
- Market Cap
- CAMT 4.1B
- HAE 3.3B
- IPO Year
- CAMT 2000
- HAE 1991
- Fundamental
- Price
- CAMT $98.35
- HAE $75.87
- Analyst Decision
- CAMT Strong Buy
- HAE Strong Buy
- Analyst Count
- CAMT 11
- HAE 10
- Target Price
- CAMT $91.82
- HAE $99.00
- AVG Volume (30 Days)
- CAMT 363.2K
- HAE 520.2K
- Earning Date
- CAMT 08-05-2025
- HAE 08-07-2025
- Dividend Yield
- CAMT 1.35%
- HAE N/A
- EPS Growth
- CAMT 46.65
- HAE 44.54
- EPS
- CAMT 2.61
- HAE 3.31
- Revenue
- CAMT $450,862,000.00
- HAE $1,360,824,000.00
- Revenue This Year
- CAMT $16.17
- HAE N/A
- Revenue Next Year
- CAMT $8.71
- HAE $7.26
- P/E Ratio
- CAMT $37.61
- HAE $22.82
- Revenue Growth
- CAMT 32.63
- HAE 3.96
- 52 Week Low
- CAMT $47.41
- HAE $55.30
- 52 Week High
- CAMT $110.73
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- CAMT 74.83
- HAE 57.85
- Support Level
- CAMT $92.50
- HAE $74.24
- Resistance Level
- CAMT $101.73
- HAE $75.53
- Average True Range (ATR)
- CAMT 3.19
- HAE 1.85
- MACD
- CAMT 0.12
- HAE -0.14
- Stochastic Oscillator
- CAMT 80.38
- HAE 66.38
About CAMT Camtek Ltd.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.